SERS–LFIA technology based on Au@Ag nanospheres for simultaneous detection of carbapenemases KPC and NDM
RSC Advances · 2026
DOI: 10.1039/d6ra08505a ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2026. Verfasst von Xueli Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory, Hospital of Xinjiang Production and Construction Corps, The Second Affiliated Hospital of Shihezi University School…. Die Arbeit nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
A SERS–lateral flow immunoassay enables rapid, specific detection of KPC- and NDM-type carbapenemases on a single T line, with high sensitivity and specificity and 100% agreement with PCR and commercial colloidal gold kits.
Autor:innen und Institutionen
- Department of Medical Laboratory, Hospital of Xinjiang Production and Construction Corps, The Second Affiliated Hospital of Shihezi University School of Medicine Urumqi Xinjiang 830002 China xjzhangxin108@126.com.
- Bingtuan Clinical Medical Research Center for Medical Laboratory Urumqi Xinjiang 830002 China.
ORCID-Profile: Xin Zhang
Zitieren
APA
Zhang, X., Shi, Q., Zha, H., Liu, C., Liang, M., & Zhang, X. (2026). SERS–LFIA technology based on Au@Ag nanospheres for simultaneous detection of carbapenemases KPC and NDM. RSC Advances. https://doi.org/10.1039/d6ra08505a
Vancouver
Zhang X, Shi Q, Zha H, Liu C, Liang M, Zhang X. SERS–LFIA technology based on Au@Ag nanospheres for simultaneous detection of carbapenemases KPC and NDM. RSC Advances. 2026. doi:10.1039/d6ra08505a
BibTeX
@article{Zhang2026,
author = {Zhang, Xueli and Shi, Qian and Zha, HeFei and Liu, Chunyan and Liang, Mengjie and Zhang, Xin},
title = {SERS–LFIA technology based on Au@Ag nanospheres for simultaneous detection of carbapenemases KPC and NDM},
journal = {RSC Advances},
year = {2026},
doi = {10.1039/d6ra08505a}
}
EUVIMED